G Trademark

Trademark Overview


On Tuesday, June 7, 2022, a trademark application was filed for G with the United States Patent and Trademark Office. The USPTO has given the G trademark a serial number of 97446036. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, September 10, 2025. This trademark is owned by SmithKline Beecham Limited. The G trademark is filed in the Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Scientific research for medical purposes in the field of pharmaceuticals, vaccines, cell and gene therapy; research and development services in the fields of bioelectronics, drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biochemicals, biotechnology, biological products, medical apparatus, devices and instruments; conducting genetic testing for research purposes; scientific research consulting; medical laboratory services; Providing medical and scientific research information; computer system design services in the nature of design of computational models and systems of artificial intelligence; medical and pharmacological research services; software development, programming and implementation; research in the field of gene and cell therapy; provision of information, consultancy and advisory services relating to any of the aforesaid services

Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; vaccines; adjuvants for medical purposes; medicated and sanitizing soaps and detergents

Medical and healthcare services; provision of medical information and medical services; information provided to patients and healthcare professionals concerning pharmaceutical products, vaccines, medical diseases and disorders and related treatments; gene and cell therapy medical treatment services; genetic testing for medical purposes; provision of information, consultancy and advisory services relating to any of the aforesaid services

Surgical apparatus and instruments for medical use; medical fluid injectors; medical apparatus and instruments for use in the diagnosis and treatment of skin diseases, conditions and disorders; transcutaneous electrical nerve stimulation devices to treat body pain; implantable electrodes for medical purposes; adaptive open and or closed-loop bioelectronic medical devices that deliver stimulation and/or blocking to a nerve and optionally can record incoming action potentials and physiological parameters, analyze data in real time and modulate neural signaling; drug delivery devices sold empty, namely, syringes for medical purposes and for injections; surgical implants comprising artificial material
g

General Information


Serial Number97446036
Word MarkG
Filing DateTuesday, June 7, 2022
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, September 10, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing5 - Drawing with word(s) / letter(s) / number(s) in Stylized form
Published for Opposition DateTuesday, July 25, 2023

Trademark Statements


Goods and ServicesScientific research for medical purposes in the field of pharmaceuticals, vaccines, cell and gene therapy; research and development services in the fields of bioelectronics, drug discovery, drug discovery products, pharmaceuticals, medicinal diagnostics, biochemicals, biotechnology, biological products, medical apparatus, devices and instruments; conducting genetic testing for research purposes; scientific research consulting; medical laboratory services; Providing medical and scientific research information; computer system design services in the nature of design of computational models and systems of artificial intelligence; medical and pharmacological research services; software development, programming and implementation; research in the field of gene and cell therapy; provision of information, consultancy and advisory services relating to any of the aforesaid services
Goods and ServicesPharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; vaccines; adjuvants for medical purposes; medicated and sanitizing soaps and detergents
Goods and ServicesMedical and healthcare services; provision of medical information and medical services; information provided to patients and healthcare professionals concerning pharmaceutical products, vaccines, medical diseases and disorders and related treatments; gene and cell therapy medical treatment services; genetic testing for medical purposes; provision of information, consultancy and advisory services relating to any of the aforesaid services
Goods and ServicesSurgical apparatus and instruments for medical use; medical fluid injectors; medical apparatus and instruments for use in the diagnosis and treatment of skin diseases, conditions and disorders; transcutaneous electrical nerve stimulation devices to treat body pain; implantable electrodes for medical purposes; adaptive open and or closed-loop bioelectronic medical devices that deliver stimulation and/or blocking to a nerve and optionally can record incoming action potentials and physiological parameters, analyze data in real time and modulate neural signaling; drug delivery devices sold empty, namely, syringes for medical purposes and for injections; surgical implants comprising artificial material
Indication of Colors claimedThe color(s) orange is/are claimed as a feature of the mark.
Description of MarkThe mark consists of stylized letter "G" appearing in orange.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 15, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateWednesday, June 15, 2022
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 15, 2022
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, June 15, 2022
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSmithKline Beecham Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressLondon WC1A1DG
GB

Party NameSmithKline Beecham Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Friday, June 10, 2022NEW APPLICATION ENTERED
Wednesday, June 15, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, August 2, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, August 2, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Tuesday, August 2, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Tuesday, August 2, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 22, 2023ASSIGNED TO EXAMINER
Friday, March 24, 2023NON-FINAL ACTION WRITTEN
Friday, March 24, 2023NON-FINAL ACTION E-MAILED
Friday, March 24, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, June 21, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, June 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, June 22, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, July 5, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 25, 2023PUBLISHED FOR OPPOSITION
Tuesday, July 25, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 19, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 5, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, March 5, 2024SOU EXTENSION 1 FILED
Tuesday, March 5, 2024SOU EXTENSION 1 GRANTED
Wednesday, March 6, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 11, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, September 11, 2024SOU EXTENSION 2 FILED
Wednesday, September 11, 2024SOU EXTENSION 2 GRANTED
Wednesday, September 11, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, October 23, 2024TEAS CHANGE OF OWNER ADDRESS RECEIVED
Wednesday, October 23, 2024APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, October 23, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 12, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, March 12, 2025SOU EXTENSION 3 FILED
Wednesday, March 12, 2025SOU EXTENSION 3 GRANTED
Thursday, March 13, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 10, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, September 10, 2025SOU EXTENSION 4 FILED
Wednesday, September 10, 2025SOU EXTENSION 4 GRANTED
Thursday, September 11, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 6, 2026SOU TEAS EXTENSION RECEIVED